Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BW.1.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BW.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BW.1.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.312NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.312NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.312NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.13.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.13.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.13.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.220NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.220NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.220NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.142NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.142NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.142NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.523NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.523NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.523NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.36.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.36.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.418NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.418NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.418NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.389NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.389NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.389NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.53NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.53NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.363NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.363NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.363NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HV.1.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HV.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.405NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.405NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.405NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.282NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.282NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.282NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.228NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.228NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-16904Singapore
B.1.1.228NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.174NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.174NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used